Beijing Suncadia Pharmaceuticals Co., Ltd
22
2
3
9
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
4.5%
1 terminated/withdrawn out of 22 trials
90.0%
+3.5% vs industry average
18%
4 trials in Phase 3/4
0%
0 of 9 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (22)
A Safety, Tolerability, Pharmacokinetic Study of SHR-6934 Injection in Healthy Subjects
Role: lead
Safety, Tolerability and Pharmacokinetic Study of HRS-8829
Role: lead
A Clinical Study of SHR-2004 Injection in Preventing Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty
Role: lead
A Study Of SHR-1918 In Participants With Hypercholesterolemia With Inadequate Lipid Control on Statins Plus PCSK9 Inhibitors
Role: lead
A Study of SHR-1918 In Participants With Hypertriglyceridemia
Role: lead
Efficacy and Safety of SHR-1918 in Patients With Hyperlipidemia
Role: lead
A Trial to Evaluate the Efficacy and Safety of SHR-1918 in Patients With Hyperlipidemia
Role: lead
Evaluate the Efficacy and Safety of SHR-1918 in Patients With Hyperlipidemic
Role: lead
A Phase I Study of SHR-2906 Injection in Healthy Subjects With a Single Dose and in Obese Patients With Multiple Doses
Role: lead
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study Evaluating the Efficacy and Safety of SHR-1918 in Patients With Homozygous Familial Hypercholesterolemia
Role: lead
A Trial of SHR-4658 in Healthy Volunteers or Volunteers With Elevated Blood Pressure
Role: lead
Evaluate the Efficacy and Safety of SHR-1918 in Patients With Homozygous Familial Hypercholesterolemia
Role: lead
The Efficacy and Safety of HRS8179 in Severe Cerebral Edema Following Large Hemispheric Infarction
Role: lead
Evaluate the Long-term Efficacy and Safety of SHR-1918 in Patients With Homozygous Familial Hypercholesterolemia
Role: lead
A Study to Evaluate the Efficacy and Safety of SHR-2004 Injection in Preventing Postoperative Venous Thromboembolism in Patients Undergoing Ovarian Cancer Surgery
Role: lead
Single Ascending Dose and Multiple Dose Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SHR-1816 in Healthy Subjects
Role: lead
A Single Ascending Dose of HRS-4029 in Healthy Subjects
Role: lead
SHR-2004 for the Prevention of Venous Thromboembolism in Patients Undergoing Total Knee Arthroplasty
Role: lead
A Trial of HRS8179 on Brain Swelling After Large Hemispheric Infarction
Role: lead
Study on the Safety and Tolerability, Pharmacokinetics and Pharmacodynamics of SHR-2004 Injection in Adult Patients With Atrial Fibrillation
Role: lead